The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy

被引：0
|
作者：
Ono, Ryohei
Fukushima, Kenichi
Takahashi, Hidehisa R.
Hori, Yasuhiko
Kobayashi, Yoshio
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15194
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Wang, Huijuan
    Zhang, Zhiyao
    Zhou, Huixing
    Chen, Wenming
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [42] Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time
    Benzon, Honorio T.
    Park, Meghan
    McCarthy, Robert J.
    Kendall, Mark C.
    Lindholm, Paul F.
    [J]. ANESTHESIA AND ANALGESIA, 2019, 128 (06): : 1089 - 1096
  • [43] Efficacy of prothrombin time and activated partial thromboplastin time as a gauge for specific factor inhibition
    Keller, C.
    Dennis, J.
    Monroe, D.
    Tidwell, R.
    Church, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 906 - 907
  • [44] PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME
    BURNS, ER
    GOLDBERG, SN
    WENZ, B
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (02) : 94 - 98
  • [45] The Correlations Between Anti-Factor Xa Activity Values and Pt-inr/aptt at Peak and Trough Times in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Hori, Yasuhiko
    Takahashi, Hidehisa
    Yamashita, Daichi
    Nishimura, Kaazutaka
    [J]. CIRCULATION, 2018, 138
  • [46] Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-Factor Xa measurements in continuous-flow left ventricular assist device patients
    Ton, Van-Khue
    Eisenberger, Andrew
    Jennings, Douglas
    Colombo, Paolo C.
    Topkara, Veli K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1365 - 1367
  • [47] Comparison of Activated Partial Thromboplastin Time (aPTT) and Anti-Factor Xa for Low Intensity Unfractionated Heparin Monitoring in Patients with Mechanical Circulatory Support Devices (MCSD)
    Volod, O.
    Lam, L. D.
    Barglowski, M.
    Mirocha, J.
    Runyan, C.
    Moriguchi, J.
    Czer, L. S.
    Arabia, F.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S443 - S443
  • [48] Distribution of anti-factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban
    Hiramatsu, Shotaro
    Osanai, Hiroyuki
    Sakai, Yuichiro
    Sogo, Yoshiki
    Tanaka, Yuki
    Matsumoto, Hikari
    Miyamoto, Shun
    Tagahara, Kensuke
    Arai, Kenji
    Watanabe, Takashi
    Sakamoto, Yusuke
    Sakaguchi, Teruhiro
    Oguchi, Shioh
    Kanbara, Takahiro
    Nakashima, Yoshihito
    Asano, Hiroshi
    Ajioka, Masayoshi
    [J]. JOURNAL OF ARRHYTHMIA, 2024,
  • [49] Components of variability of activated partial thromboplastin time (APTT) vs. anti-factor Xa (AXa) on unfractionated heparin (UFH) dose adjustments
    Guerrero, F.
    Faure, A.
    Diemert, V
    Voisin, S.
    Sie, P.
    Riviere, Bura A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 683 - 684
  • [50] Concordance Between Active Partial Thromboplastin Time and Anti-Factor Xa Assays in Neurocritically Ill Patients Receiving Subcutaneous Heparin Prophylaxis
    Shinn, Grace
    Berger, Karen
    Roh, David
    Doyle, Kevin
    Boehme, Amelia K.
    Connolly, Edward Sander
    Park, Soojin
    Agarwal, Sachin
    Claassen, Jan
    Der-Nigoghossian, Caroline
    [J]. NEUROHOSPITALIST, 2023, 13 (03): : 221 - 227
12345